<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="polymerase, such as ganciclovir, valganciclovir, cidofovir, and foscarnet. At present," exact="ganciclovir" post="remains to be the first line drug for the"/>
 <result pre="line drug for the treatment of CMV infections. Ganciclovir and" exact="valganciclovir" post="are mainly used for both preemptive therapy and prophylaxis"/>
 <result pre="[62]. However, it is not recommended to co-administer maribavir and" exact="ganciclovir" post="because maribavir is an inhibitor of the UL97 enzyme"/>
 <result pre="is commonly used when patients present with drug resistance (e.g.," exact="ganciclovir" post="and valganciclovir) [62,69]. Additionally, it is likely to be"/>
 <result pre="compounds because of its reduced haematotoxicity and nephrotoxicity, compared with" exact="ganciclovir" post="and valganciclovir [62]. Maribavir has been used to treat"/>
 <result pre="of its reduced haematotoxicity and nephrotoxicity, compared with ganciclovir and" exact="valganciclovir" post="[62]. Maribavir has been used to treat hematopoietic cell"/>
 <result pre="Brincidofovir Brincidofovir (CMX001) is an orally bioavailable lipid prodrug of" exact="cidofovir" post="which is less renal toxic than the parent compound."/>
 <result pre="is poor despite surgical resection, high-dose radiation, and chemotherapy with" exact="temozolomide" post="[88,89]. Activation of the immune system against tumor cells"/>
 <result pre="tissues. Batich et al. evaluated pp65-specific cellular responses following dose-intensified" exact="temozolomide" post="(DI-TMZ) with pp65- DCs and determined the effects on"/>
 <result pre="[94]. Following tumor resection, the patient received radiation therapy and" exact="temozolomide" post="combined therapy that was complicated by CMV colitis and"/>
 <result pre="foscarnet therapy remodels thymidine analogue mutations and alters resistance to" exact="zidovudine" post="and lamivudine in HIV-1Antivir. Ther.20071233534317591023 60.StuppR.MasonW.P.van den BentM.J.WellerM.FisherB.TaphoornM.J.BelangerK.BrandesA.A.MarosiC.BogdahnU.et al.Radiotherapy"/>
 <result pre="remodels thymidine analogue mutations and alters resistance to zidovudine and" exact="lamivudine" post="in HIV-1Antivir. Ther.20071233534317591023 60.StuppR.MasonW.P.van den BentM.J.WellerM.FisherB.TaphoornM.J.BelangerK.BrandesA.A.MarosiC.BogdahnU.et al.Radiotherapy plus concomitant"/>
 <result pre="HIV-1Antivir. Ther.20071233534317591023 60.StuppR.MasonW.P.van den BentM.J.WellerM.FisherB.TaphoornM.J.BelangerK.BrandesA.A.MarosiC.BogdahnU.et al.Radiotherapy plus concomitant and adjuvant" exact="temozolomide" post="for glioblastomaN. Engl. J. Med.200535298799610.1056/NEJMoa04333015758009 61.OrnaghiS.HsiehL.S.BordeyA.VerganiP.PaidasM.J.van den PolA.N.Valnoctamide Inhibits"/>
</results>
